Evaluation and compensation of new biomarker tests

During the 7th HTA Confernce on April 29, our Scientific Director Panos Stafylas highlighted the need to develop and adopt an effective system of evaluation and compensation of new biomarker tests.

You can read in more details his suggestions and proposals on the article here.